 PLYMOUTH MEETING, Pa., Oct. 26, 2021 PRNewswire -- Harmony Biosciences Holdings, Inc. Harmony or the Company Nasdaq: HRMY, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a press release on the Companys third quarter 2021 financial results on Tuesday, November 9, 2021. 